Franklin Resources
ABOS icon

Franklin Resources’s Acumen Pharmaceuticals ABOS Stock Holding History

Franklin Resources’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.44M Hold
2,305,096
– – ﹤0.01% 1485
2025
Q4 		$4.86M Hold
2,305,096
– – ﹤0.01% 1411
2025
Q3 		$3.94M Sell
2,305,096
-771,943
-25% -$1.07M ﹤0.01% 1517
2025
Q2 		$3.57M Sell
3,077,039
-64,900
-2% -$69.8K ﹤0.01% 1490
2025
Q1 		$3.46M Sell
3,141,939
-131,694
-4% -$188K ﹤0.01% 1487
2024
Q4 		$5.63M Sell
3,273,633
-275,436
-8% -$663K ﹤0.01% 1301
2024
Q3 		$8.34M Buy
3,549,069
+181,451
+5% +$492K ﹤0.01% 1184
2024
Q2 		$8.15M Sell
3,367,618
-27,800
-0.8% -$88.5K ﹤0.01% 1145
2024
Q1 		$13.8M Buy
3,395,418
+36,609
+1% +$138K ﹤0.01% 974
2023
Q4 		$12.9M Buy
3,358,809
+520,044
+18% +$1.54M 0.01% 875
2023
Q3 		$11.8M Buy
+2,838,765
New +$17.5M 0.01% 876
2022
Q1 		– Sell
-602,266
Closed -$4.07M – 2432
2021
Q4 		$4.07M Sell
602,266
-335,234
-36% -$3.68M ﹤0.01% 1282
2021
Q3 		$13.9M Buy
+937,500
New +$15.6M 0.01% 980

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Franklin Resources's ABOS Position: Q1 2026 in Review

Franklin Resources held its Acumen Pharmaceuticals (ABOS) position steady in Q1 2026 at 2,305,096 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Franklin Resources first reported a position in ABOS in Q3 2021 and has held it in 13 quarters since. The position peaked at $13.9M in Q3 2021. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Franklin Resources held 2,305,096 shares of Acumen Pharmaceuticals worth $5.44M as of Q1 2026.
  • Franklin Resources left its Acumen Pharmaceuticals share count unchanged in Q1 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1485 holding.
  • Franklin Resources first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • Franklin Resources's Acumen Pharmaceuticals position peaked at $13.9M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.